/V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized, Controlled RELIEVE-HF Trial of the Ventura® Interatrial Shunt Showing Reduced Clinical Events in Advanced Heart Failure Patients with Reduced Left Ventricular Ejection Fraction

NEWS

V-Wave Announces Late-Breaking Primary Results from Pivotal, Double-Blind, Randomized, Controlled RELIEVE-HF Trial of the Ventura® Interatrial Shunt Showing Reduced Clinical Events in Advanced Heart Failure Patients with Reduced Left Ventricular Ejection Fraction

PRNewswire

2024/04/06

V-Wave is a privately held medical device company with offices in Israel and the U.S. For more information, please visit www.vwavemedical.com. (PRNewsfoto/V-Wave Ltd.)

V-Wave® Ventura® Interatrial Shunt (PRNewsfoto/V-Wave Ltd.)

Summary

Results presented at ACC.24 showed that overall neutral results were due to directionally opposite effects in patients with reduced vs. preserved left...